Enteris, Ferring deal

Enteris granted Ferring exclusive, worldwide rights to Enteris' oral drug delivery technologies, including Peptelligence, to develop and commercialize an oral formulation of an undisclosed peptide-based injectable therapeutic for an undisclosed indication. Enteris, which is eligible for undisclosed milestones and royalties, will also provide clinical trial finished product to Ferring...